Top Marijuana Shares in the NASDAQ

Even though the most of U.S.-based cannabis businesses and several foreign American Depository Receipts (ADRs) trade on the countertop (OTC), a marijuana that is few are traded in the NASDAQ. Some investors prefer shares which are noted on the NASDAQ to many other exchanges because of their increased liquidity and tighter spreads when compared to markets that are over-the-counter. For instance, while the cannabis industry has exploded in present months and years, uplisting from an OTC market to an established U.S. trade is becoming a advertising achievement for a lot of marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

An number that is increasing of businesses are now being noted on reputable U.S. exchanges as opposed to being exchanged regarding the OTC market showing the fast development of the cannabis industry.

NASDAQ-listed Marijuana Stocks

The NASDAQ had been the initial electronic change and is definitely synonymous with technology and biotechnology. The cannabis businesses in the NASDAQ mirror this, therefore the most of them run when you look at the area that is biotech of industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical purchase, as of October 26, 2019, with a failure of the total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is just a biotech company mixed up in production of medical cannabis drugs. Research and development around Arena’s APD371 could be the focus that is primary of company’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is really a blank check business that is currently in a merger agreement with Kalyx developing Inc. Kalyx is a respected owning a home rely upon the regulated cannabis industry in america.

Key Takeaways

  • The cannabis industry, specially the part of cannabis and biotech, is attracting investor attention that is substantial.
  • Cannabis has been found in brand new medications to treat discomfort and numerous chronic, inflammatory, and fibrotic conditions.
  • Businesses will also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette syndrome, epileptic disorders, Prader-Willi Syndrome (an inherited condition), and amphetamine addiction.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is really a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of discomfort and pruritus (itching). Although most of the company’s clinical-stage services and products target opioid receptors, Cara happens to be performing research that is preclinical cannabinoids for the treatment of neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech business. The team’s research, development, and production are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, along with other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is really A canadian cannabis business. The team has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced intends to spend $1.8 billion in Cronos. The investment has provided Cronos not just with additional money to finance its continued expansion but additionally by having a partner that is well-established in the advertising of consumer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis consumption add-ons and vaporization gear and items to retail clients in the U.S. and Canada. Also, it runs websites that are e-commerce additional sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is having a profile of cannabinoid medications. These medications include Sativex for the treatment of spasticity pertaining to multiple sclerosis and cancer tumors discomfort and Epidiolex to treat childhood epilepsy. Sativex is commercialized much more than the usual dozen nations away from United States and has gotten approval that is regulatory some other nations. Epidiolex received Food And Drug Administration approval being a therapy plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very very early beginning epilepsy without good existing treatment plans. Other indications show that GW Pharmaceuticals is developing cannabinoid services and products for autism spectrum disorders, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical business that is developing drugs centered on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest administration and plant health items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now legal to be used on cannabis crops within the Ca cultivation market.

Modern Age Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is just a maker of beverages based on yerba mate, green tea leaf, kombucha, and similar items. In current months, modern age has expanded its beverage offerings to add CBD infusions also, bringing it into the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted in the NASDAQ in might of 2019, rendering it probably one of the most present cannabis organizations to record from the popular change. The business happens to be quickly expanding its manufacturing capacity and might manage to create just as much as 113,000 kilograms of item per 12 months by the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs when you look at the enforcement sector. The company’s business operations support medication evaluation through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is yet another brand new entry on the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a brief cost boost) whenever it announced the production of a unique Palmetto brand of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage pharmaceutical company focused from the growth of cannabinoid-based medications. Therapix’s present pipeline includes items targeted to treat Tourette problem and mild intellectual impairment.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. was initial marijuana-related company to have a preliminary general public providing (IPO) in the usa. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis products.

Village Farms Global (NASDAQ:VFF)

Village Farms Global is considered the most cannabis that are recent to begin dealing from the NASDAQ. The business’s stocks became readily available for trade on February 21, 2019. The business features a decades-long history in greenhouse produce manufacturing and it has just recently shifted a few of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted from the growth of synthetic cannabinoid remedies for transdermal (through skin) distribution. Their pipeline currently includes two medications being developed for indications including epilepsy, osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.

Leave a Reply

Latest E.I Facebook Update

No recent Facebook posts to show

News & Events